[HBsAg and anti-HBs in thalassemia non-transfused patients (and in their relatives)].
The sera obtained from 105 non transfused adult heterozygous thalassaemic subjects and from 119 members of 25 thalassaemic families have been tested with radioimmunoassay methods for the presence of HBsAg and anti-HBs. 11 out of 105 thalassaemic patients (10.4%) showed HBsAg in their serum and 41 (40%) anti-HBs antibodies. Family studies revealed that the incidence of HBsAg was 8.9% in 89 thalassaemic members and 10% in 30 non thalassaemic relatives. The incidence of anti-HBs was 34.8% and 13.3% respectively. The frequency of HBsAg in thalassaemic subjects, independently of blood transfusion as shown by our data, suggests some difficulty in eliminating the antigen. So these subjects become rather easily carriers of the antigen and source of the infection particularly in the family.
D000328:Adult; D000914:Antibodies, Viral / Q000032:analysis*; D001803:Blood Transfusion; D002353:Carrier State; D006510:Hepatitis B Antibodies / Q000032:analysis*; D006514:Hepatitis B Surface Antigens / Q000032:analysis*; D006801:Humans; D011863:Radioimmunoassay; D013789:Thalassemia / Q000235:genetics / Q000276:immunology*
D000914:Antibodies, Viral; D006510:Hepatitis B Antibodies; D006514:Hepatitis B Surface Antigens
L'HBsAg e l'anti-HBs in soggetti con emopatia mediterranea non trasfusi (e nei loro familiari).